No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
COO240719C90000
- 1.83
- +0.73+66.36%
15min DelayClose Jul 12 16:00 ET
1.90High0.85Low
0.85Open1.10Pre Close57 Volume438 Open Interest90.00Strike Price9.31KTurnover17.44%IV1.12%PremiumJul 19, 2024Expiry Date0.81Intrinsic Value100Multiplier5DDays to Expiry1.02Extrinsic Value100Contract SizeAmericanOptions Type0.6739Delta0.1777Gamma68.54Leverage Ratio-0.0720Theta0.0098Rho46.19Eff Leverage0.0419Vega
Intraday
- 5D
- Daily
News
Cooper Cos Is Maintained at Overweight by Piper Sandler
Cooper Cos Is Maintained at Overweight by Piper Sandler
Cooper Companies Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/03/2024 35.07% Piper Sandler $115 → $115 Maintains Overweight 05/31/2024 38.6% Baird $116 → $118 Mainta
Piper Sandler Maintains Cooper Companies(COO.US) With Buy Rating, Maintains Target Price $115
Piper Sandler analyst Jason Bednar maintains $Cooper Companies(COO.US)$ with a buy rating, and maintains the target price at $115.According to TipRanks data, the analyst has a success rate of 35.2% an
Cooper Co (COO) Gets a Buy From Piper Sandler
Evolus: White Is Pres and CEO of the Cooper Companies >EOLS
Evolus: White Is Pres and CEO of the Cooper Companies >EOLS
Evolus Announces Appointment of Albert G. White III to Board of Directors
Evolus, Inc. (NASDAQ:EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced the appointment of Albert G. White III, President and Chief Executive Officer
Comments
Investors maintain a high P/E ratio for Cooper Companies despite earnings decline, buoyed by strong forecasted growth. This is expected to continue supporting the share price.
Why Investors Shouldn't Be Surprised By The Cooper Companies, Inc.'s (NASDAQ:COO) P/E 1
Jonathan Banas, executive vice president and chief financial officer, expressed delight at the appointment of Nudd, praising her as an invaluable and energetic leader within the finance function at Cooper Standard.
Cooper Companies' decreasing ROCE and stagnant sales despite reinvestment don't suggest a potential multi-bagger. The past five-year return indicates awareness of these trends. Consider other options for a multi-bagger.
Baird advocates medtech companies such as Alcon, Stryker, and Cooper due to product and pricing strengths. Belief is strong in Alcon's 2024 margin possibilities, Stryker's premium pricing and predicted robust orthopedic demand, and projected revenue growth for Boston Scientific and Axonics.
Cooper Companies' high P/E ratio is backed by robust earnings growth outlook. Shareholders are holding onto their stocks due to the expected superior future earnings growth.
Read more